Dresden has become one of Germany’s most trusted centers for oncology and hematology, offering access to highly experienced onco-hematologists who specialize in diagnosing and treating blood cancers and related disorders. These include leukemia, lymphoma, multiple myeloma, and bone marrow diseases. The city’s medical institutions combine precision diagnostics, targeted therapy, and stem cell transplantation programs supported by strong research and advanced laboratory medicine. Patients from across Europe and beyond choose Dresden for its balance of cutting-edge treatments and compassionate, patient-centered care.
The onco-hematology network in Dresden benefits from collaboration between the University Hospital Carl Gustav Carus Dresden, the National Center for Tumor Diseases (NCT/UCC Dresden), and other specialized clinics. According to hospital data, the hematology and oncology departments at the University Hospital manage over 4,000 inpatients and 20,000 outpatients annually, including patients undergoing stem cell transplantation. Dresden’s NCT/UCC center also runs more than 200 active clinical trials in cancer and blood disorders, providing patients access to innovative therapies such as immunotherapy and cellular treatment. This integration of science, clinical care, and technology has established Dresden as one of Germany’s leading cities for onco-hematology.
Patients seeking advanced blood cancer and hematology treatment turn to Dresden for its combination of high expertise, modern facilities, and multidisciplinary collaboration.
➤ Comprehensive cancer and blood disorder care: Dresden’s specialists provide full-spectrum care, including chemotherapy, immunotherapy, targeted therapy, and bone marrow transplantation.**
➤ Highly qualified onco-hematologists: Doctors in Dresden are internationally recognized for their clinical research, teaching, and patient outcomes in hematologic oncology.**
➤ Cutting-edge diagnostic and treatment technology: Clinics use advanced molecular genetics, next-generation sequencing, and precision medicine for personalized cancer care.**
➤ Access to clinical trials and innovative therapies: Patients can participate in leading-edge treatment programs developed through collaboration with the German Cancer Research Center (DKFZ) and NCT Dresden.**
➤ Multidisciplinary teamwork: Onco-hematologists in Dresden work closely with radiologists, pathologists, and transplant specialists to design integrated treatment plans.**
➤ Supportive environment for international patients: Many institutions have dedicated international departments offering language assistance, travel coordination, and personalized medical guidance.**
Prof. Dr. Gerhard Ehninger
Prof. Ehninger is one of Germany’s most distinguished hematologists and co-founder of the National Center for Tumor Diseases Dresden. He has decades of experience in treating leukemia and lymphomas, with numerous contributions to clinical research and international collaboration in stem cell therapy.
Prof. Dr. Michael Albrecht
Speciality expertise: Oncology and internal medicine with a focus on solid and hematologic cancers.
Prof. Albrecht is a senior consultant at the University Hospital Carl Gustav Carus, where he oversees the integration of advanced cancer therapies and academic research. His clinical leadership has helped establish Dresden as a hub for onco-hematology innovation.
Prof. Dr. Michael Cross
Speciality expertise: Hematologic oncology and molecular diagnostics.
Prof. Cross works at the NCT Dresden and specializes in translational hematology research. His clinical work emphasizes individualized cancer therapies through molecular profiling and targeted drug design.
Dr. Sandra Behrens
Speciality expertise: Multiple myeloma, lymphoma, and chemotherapy management.
Dr. Behrens is an experienced hematologist at Städtisches Klinikum Dresden. She is known for her patient-oriented approach and expertise in managing complex chemotherapy regimens with supportive care for enhanced recovery.
Prof. Dr. Gerald Wulf
Speciality expertise: Acute leukemia, bone marrow transplantation, and immunotherapy.
Prof. Wulf leads research collaborations between NCT Dresden and international centers focusing on improving long-term outcomes for leukemia patients. He is well-respected for his clinical precision and contribution to cellular immunotherapy advancements.
Finding specialized cancer care abroad requires careful planning, reliable medical coordination, and emotional support. Best Clinic Abroad makes this process simpler by connecting patients with Dresden’s leading onco-hematologists and providing end-to-end assistance from consultation to follow-up care.
➤ Personalized case review: Each patient’s medical file is assessed to connect them with the most suitable onco-hematologist and treatment program in Dresden.
➤ Free online consultation: Patients can discuss treatment options, prognosis, and possible clinical trial participation before traveling.
➤ Clinic and doctor coordination: Partnerships with top institutions such as the University Hospital Carl Gustav Carus and NCT Dresden ensure access to the best specialists.
➤ Transparent cost and treatment planning: Patients receive detailed treatment plans, timelines, and cost breakdowns for clarity and confidence.
➤ Travel and visa support: Assistance with medical visa processing, flights, and accommodation near the treatment facility.
➤ Interpreter and local support: Multilingual coordinators guide patients through hospital visits, appointments, and ongoing care during treatment.
With Best Clinic Abroad, patients can access Dresden’s world-class onco-hematology expertise while receiving compassionate, coordinated support every step of the way. From diagnosis to recovery, every detail is managed with professionalism and care — helping patients focus on healing and hope through trusted cancer and blood disorder treatment in Dresden.
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
How it works?
